Bioprinting of Complex Vascularized Tissues

Area of Science:

• Biomedical Engineering
• Tissue Engineering
• Regenerative Medicine

Background:

• Vascularization is essential for engineered tissue survival, but mass transport limitations hinder the development of thick tissues.
• Insufficient blood vessel networks lead to cell death and necrosis in engineered constructs.
• Current tissue engineering methods struggle to create functional, vascularized tissues with complex architectures.

Purpose of the Study:

• To develop and present a novel microscale continuous optical bioprinting (μCOB) platform.
• To demonstrate the capability of μCOB for high-resolution, rapid 3D printing of vascularized tissues.
• To address the limitations of mass transport and diffusional constraints in thick engineered tissues.

Main Methods:

• Development of a microscale continuous optical bioprinting (μCOB) system.
• 3D printing of endothelial cells and supportive cells directly into hydrogel scaffolds.
• Utilizing precise control over cell distribution and spatial organization.
• In vitro culture to promote the formation of lumen-like structures.

Main Results:

• Successful development of a μCOB platform for 3D bioprinting.
• Demonstrated superior resolution and speed in printing vascularized tissue constructs.
• Achieved precise spatial distribution of endothelial and supportive cells within hydrogels.
• Observed in vitro formation of lumen-like structures, indicating early vascular development.

Conclusions:

• The μCOB platform offers a promising solution for creating vascularized engineered tissues.
• This technology can overcome critical mass transport and diffusional limitations in tissue engineering.
• μCOB facilitates the development of complex, functional tissues with potential therapeutic applications.